Antengene Corporation Ltd
HKEX:6996
Antengene Corporation Ltd
Other Current Assets
Antengene Corporation Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Antengene Corporation Ltd
HKEX:6996
|
Other Current Assets
¥24m
|
CAGR 3-Years
72%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Current Assets
¥234.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Other Current Assets
¥7.1B
|
CAGR 3-Years
191%
|
CAGR 5-Years
109%
|
CAGR 10-Years
72%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Current Assets
¥1.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
24%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Current Assets
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
24%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Other Current Assets
¥160.4m
|
CAGR 3-Years
57%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Antengene Corporation Ltd
Glance View
Antengene Corp. Ltd. operates as clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
See Also
What is Antengene Corporation Ltd's Other Current Assets?
Other Current Assets
24m
CNY
Based on the financial report for Dec 31, 2024, Antengene Corporation Ltd's Other Current Assets amounts to 24m CNY.
What is Antengene Corporation Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
82%
Over the last year, the Other Current Assets growth was -17%. The average annual Other Current Assets growth rates for Antengene Corporation Ltd have been 72% over the past three years , 82% over the past five years .
You don't have any saved screeners yet